The Thousand Oaks, Calif.-based biotech pharmaceutical company makes drugs that treat patients in about 100 countries.
Looking for leads, investment insights, or competitive intelligence?
News about Amgen
Aimovig apparently cuts migraine days significantly.
Novartis and Amgen want to find out with an experimental drug.
The FDA approved the first cancer medicine "biosimilar" Thursday.
Scientists are ready to move an experimental treatment into phase 1 trials.